Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Clinical significance of immune checkpoint proteins in HPV-infected cervical cancer

Journal of Infection and Public Health(2023)10.1016/j.jiph.2023.01.019Source: DataRank Database

Clinical significance of immune checkpoint proteins in HPV-infected cervical cancer is a research paper published in Journal of Infection and Public Health (2023). On theSindex it has a DataRank of 0.510. It has been cited 29 times.

N/A

0.510DataRank · unranked

Scored on demand from live citation data

29 citations

Free full text

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 3.38)OA: goldTopics (26)Linked Datasets (16)DataCite Reuse (16)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (0/2)

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.510

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (7)

Rui Huang ORCID,Peihang Li,Xiang Liu ORCID,Qingyu Huang,Jinbo Yue

Live enrichment

PubMed:36801634 OpenAlex:https://openalex.org/W4318561896

National Natural Science Foundation of China

Grant: 81871895

Shandong Province Natural Science Foundation

Grant: ZR2021QH006

FWCI

3.38

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.jiph.2023.01.019

publisherhttps://doi.org/10.1016/j.jiph.2023.01.019

publisherhttps://api.elsevier.com/content/article/PII:S1876034123000291?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1876034123000291?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36801634

Fields of Study

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesColorectal and Anal Carcinomas

MeSH Terms

Immune Checkpoint ProteinsClinical RelevanceHuman Papillomavirus VirusesUterine Cervical NeoplasmsFemaleHumansPrognosisReceptors, ImmunologicRetrospective StudiesPapillomavirus Infections

Keywords

TIGITProportional hazards modelUnivariate analysisMedicineOncologyInternal medicineSurvival analysisCervical cancerUnivariateCancerMultivariate analysisImmunotherapyMultivariate statistics

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 7 of Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis

10.6084/m9.figshare.26648622.v1figshare

Additional file 7 of Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis

10.6084/m9.figshare.26648622figshare

Additional file 8 of Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis

10.6084/m9.figshare.26648625.v1figshare

Additional file 8 of Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis

10.6084/m9.figshare.26648625figshare

Additional file 5 of Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis

10.6084/m9.figshare.26648616figshare

Additional file 6 of Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis

10.6084/m9.figshare.26648619.v1figshare

Additional file 6 of Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis

10.6084/m9.figshare.26648619figshare

Additional file 3 of Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis

10.6084/m9.figshare.26648610figshare

Additional file 4 of Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis

10.6084/m9.figshare.26648613figshare

Additional file 4 of Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis

10.6084/m9.figshare.26648613.v1figshare

Additional file 5 of Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis

10.6084/m9.figshare.26648616.v1figshare

Additional file 1 of Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis

10.6084/m9.figshare.26648604.v1figshare

Additional file 2 of Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis

10.6084/m9.figshare.26648607figshare

Additional file 3 of Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis

10.6084/m9.figshare.26648610.v1figshare

Additional file 1 of Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis

10.6084/m9.figshare.26648604figshare

Additional file 2 of Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis

10.6084/m9.figshare.26648607.v1figshare